FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198691817> ?p ?o ?g. }

• W3198691817 endingPage "105279" @default.
• W3198691817 startingPage "105279" @default.
• W3198691817 abstract "Staphylococcus aureus is the one of the most successful modern pathogens. The same bacterium that lives as a skin and mucosal commensal can be transmitted in health-care and community-settings and causes severe infections. Thus, there is a great challenge for a discovery of novel anti-Staphylococcus aureus compounds, which should act against resistant strains. Herein, we designed and synthesized a series of 17 chalcones, substituted by amino group on ring A, which were evaluated against methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus MRSA planktonic cells. The antibacterial potency was improved by substituents on ring B, which were designed according to Topliss’ manual method. 4-bromo-3′-aminochalcone (5f) was the most active, demonstrating minimum inhibitory concentration (MIC) values of 1.9 μg mL−1 and 7.8 µg mL−1 against MSSA and MRSA, respectively. The association of 5f with vancomycin demonstrated synergistic effect against MSSA and MRSA, with Fractional Inhibitory Concentration Index (FICI) values of 0.4 and 0.3, respectively. Subinhibitory concentration of 5f inhibited the MSSA and MRSA adhesion to human keratinocytes. Chalcone 5f was able to reduce MSSA and MRSA biofilm formation, as well as acts on preformed biofilm in concentration-dependent mode. Scanning electron microscopy analyses confirmed severe perturbations caused by 5f on MSSA and MRSA biofilm architecture. The acute toxicity assay, using Galleria mellonella larvae, indicated a low toxic effect of 5f after 72 h, displaying lethality of 20% and 30% at 7.8 μg mL−1 and 78.0 μg mL−1, respectively. In addition, the antibacterial activity spectrum of 5f indicated action against planktonic cells of Enterococcus faecalis (MIC = 7.8 μg mL−1), Acinetobacter baumannii (MIC = 15.6 μg mL−1) and Mycobacterium tuberculosis (MIC = 5.7 μg mL−1). Altogether, these results open new avenues for 5f as an anti-Staphylococcus aureus agent, with potential applications as antibacterial drug, adjunct of antibiotics and medical devices coating." @default.
• W3198691817 created "2021-09-13" @default.
• W3198691817 creator A5002164671 @default.
• W3198691817 creator A5008167166 @default.
• W3198691817 creator A5018517005 @default.
• W3198691817 creator A5034525232 @default.
• W3198691817 creator A5039809457 @default.
• W3198691817 creator A5048114099 @default.
• W3198691817 creator A5048423669 @default.
• W3198691817 creator A5057731661 @default.
• W3198691817 creator A5071586067 @default.
• W3198691817 creator A5086061321 @default.
• W3198691817 date "2021-11-01" @default.
• W3198691817 modified "2023-10-12" @default.
• W3198691817 title "Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms" @default.
• W3198691817 cites W1547119536 @default.
• W3198691817 cites W1964003186 @default.
• W3198691817 cites W1966070420 @default.
• W3198691817 cites W1974690951 @default.
• W3198691817 cites W1981045094 @default.
• W3198691817 cites W1981470434 @default.
• W3198691817 cites W1983700373 @default.
• W3198691817 cites W1983784984 @default.
• W3198691817 cites W1989369576 @default.
• W3198691817 cites W1989797392 @default.
• W3198691817 cites W1993216838 @default.
• W3198691817 cites W2000923166 @default.
• W3198691817 cites W2003187506 @default.
• W3198691817 cites W2004751313 @default.
• W3198691817 cites W2010428513 @default.
• W3198691817 cites W2014595901 @default.
• W3198691817 cites W2015124098 @default.
• W3198691817 cites W2016562927 @default.
• W3198691817 cites W2018464010 @default.
• W3198691817 cites W2021137848 @default.
• W3198691817 cites W2024979288 @default.
• W3198691817 cites W2025957152 @default.
• W3198691817 cites W2027375167 @default.
• W3198691817 cites W2033982758 @default.
• W3198691817 cites W2035158221 @default.
• W3198691817 cites W2036989796 @default.
• W3198691817 cites W2044909193 @default.
• W3198691817 cites W2048883883 @default.
• W3198691817 cites W2050088246 @default.
• W3198691817 cites W2053260150 @default.
• W3198691817 cites W2066749591 @default.
• W3198691817 cites W2098533519 @default.
• W3198691817 cites W2100913335 @default.
• W3198691817 cites W2101052440 @default.
• W3198691817 cites W2106503480 @default.
• W3198691817 cites W2111170264 @default.
• W3198691817 cites W2116128143 @default.
• W3198691817 cites W2129745028 @default.
• W3198691817 cites W2130436333 @default.
• W3198691817 cites W2146401071 @default.
• W3198691817 cites W2156382695 @default.
• W3198691817 cites W2158458733 @default.
• W3198691817 cites W2165732309 @default.
• W3198691817 cites W2166227322 @default.
• W3198691817 cites W2370329710 @default.
• W3198691817 cites W2517812517 @default.
• W3198691817 cites W2524602908 @default.
• W3198691817 cites W2585745680 @default.
• W3198691817 cites W2613820968 @default.
• W3198691817 cites W2626779258 @default.
• W3198691817 cites W2732816359 @default.
• W3198691817 cites W2751997632 @default.
• W3198691817 cites W2792067847 @default.
• W3198691817 cites W2805480166 @default.
• W3198691817 cites W2928990964 @default.
• W3198691817 cites W2946660726 @default.
• W3198691817 cites W2947152834 @default.
• W3198691817 cites W2951214222 @default.
• W3198691817 cites W2962720936 @default.
• W3198691817 cites W778585144 @default.
• W3198691817 cites W90930550 @default.
• W3198691817 cites W950347584 @default.
• W3198691817 cites W2081415629 @default.
• W3198691817 doi "https://doi.org/10.1016/j.bioorg.2021.105279" @default.
• W3198691817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34509799" @default.
• W3198691817 hasPublicationYear "2021" @default.
• W3198691817 type Work @default.
• W3198691817 sameAs 3198691817 @default.
• W3198691817 citedByCount "8" @default.
• W3198691817 countsByYear W31986918172022 @default.
• W3198691817 countsByYear W31986918172023 @default.
• W3198691817 crossrefType "journal-article" @default.
• W3198691817 hasAuthorship W3198691817A5002164671 @default.
• W3198691817 hasAuthorship W3198691817A5008167166 @default.
• W3198691817 hasAuthorship W3198691817A5018517005 @default.
• W3198691817 hasAuthorship W3198691817A5034525232 @default.
• W3198691817 hasAuthorship W3198691817A5039809457 @default.
• W3198691817 hasAuthorship W3198691817A5048114099 @default.
• W3198691817 hasAuthorship W3198691817A5048423669 @default.
• W3198691817 hasAuthorship W3198691817A5057731661 @default.
• W3198691817 hasAuthorship W3198691817A5071586067 @default.
• W3198691817 hasAuthorship W3198691817A5086061321 @default.
• W3198691817 hasConcept C176947019 @default.

• next